Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6556 | 1401 | 29.1 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
116 | 23742 | STAPHYLOCOCCUS AUREUS//MRSA//METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LINEZOLID | Author keyword | 352 | 54% | 33% | 457 |
2 | OXAZOLIDINONE | Author keyword | 52 | 37% | 8% | 112 |
3 | LINEZOLID RESISTANCE | Author keyword | 45 | 83% | 2% | 25 |
4 | OXAZOLIDINONES | Author keyword | 40 | 36% | 6% | 90 |
5 | EPEREZOLID | Author keyword | 20 | 100% | 1% | 9 |
6 | CFR GENE | Author keyword | 15 | 88% | 0% | 7 |
7 | G2576T MUTATION | Author keyword | 11 | 100% | 0% | 6 |
8 | ZAAPS | Author keyword | 11 | 100% | 0% | 6 |
9 | OXAZOLIDINONE RESISTANCE | Author keyword | 9 | 83% | 0% | 5 |
10 | RANBEZOLID | Author keyword | 9 | 83% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LINEZOLID | 352 | 54% | 33% | 457 | Search LINEZOLID | Search LINEZOLID |
2 | OXAZOLIDINONE | 52 | 37% | 8% | 112 | Search OXAZOLIDINONE | Search OXAZOLIDINONE |
3 | LINEZOLID RESISTANCE | 45 | 83% | 2% | 25 | Search LINEZOLID+RESISTANCE | Search LINEZOLID+RESISTANCE |
4 | OXAZOLIDINONES | 40 | 36% | 6% | 90 | Search OXAZOLIDINONES | Search OXAZOLIDINONES |
5 | EPEREZOLID | 20 | 100% | 1% | 9 | Search EPEREZOLID | Search EPEREZOLID |
6 | CFR GENE | 15 | 88% | 0% | 7 | Search CFR+GENE | Search CFR+GENE |
7 | G2576T MUTATION | 11 | 100% | 0% | 6 | Search G2576T+MUTATION | Search G2576T+MUTATION |
8 | ZAAPS | 11 | 100% | 0% | 6 | Search ZAAPS | Search ZAAPS |
9 | OXAZOLIDINONE RESISTANCE | 9 | 83% | 0% | 5 | Search OXAZOLIDINONE+RESISTANCE | Search OXAZOLIDINONE+RESISTANCE |
10 | RANBEZOLID | 9 | 83% | 0% | 5 | Search RANBEZOLID | Search RANBEZOLID |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | U 100766 | 124 | 83% | 5% | 71 |
2 | U 100592 | 120 | 83% | 5% | 68 |
3 | DUP 721 | 89 | 100% | 2% | 27 |
4 | 3 ARYL 2 OXOOXAZOLIDINES | 79 | 88% | 3% | 37 |
5 | OXAZOLIDINONE | 71 | 61% | 5% | 76 |
6 | OXAZOLIDINONE ANTIBACTERIAL AGENTS | 63 | 63% | 4% | 63 |
7 | PRODRUG TR 701 | 38 | 93% | 1% | 14 |
8 | PNU 100766 | 32 | 88% | 1% | 15 |
9 | CFR | 25 | 62% | 2% | 26 |
10 | OXAZOLIDINONES | 24 | 27% | 6% | 78 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The emerging problem of linezolid-resistant Staphylococcus | 2013 | 47 | 36 | 81% |
Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms | 2014 | 10 | 109 | 90% |
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome | 2012 | 52 | 95 | 73% |
Presence and dissemination of the multiresistance gene cfr in Gram-positive and Gram-negative bacteria | 2013 | 25 | 42 | 81% |
Recent development of potent analogues of oxazolidinone antibacterial agents | 2013 | 22 | 90 | 83% |
Linezolid: The first oxazolidinone antimicrobial | 2003 | 234 | 32 | 84% |
Oxazolidinone structure-activity relationships leading to linezolid | 2003 | 240 | 34 | 82% |
Linezolid: a review of safety and tolerability | 2009 | 63 | 78 | 56% |
Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature | 2014 | 6 | 22 | 73% |
Oxazolidinones: activity, mode of action, and mechanism of resistance | 2004 | 126 | 54 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEV EVALUAT CHEM HERBAL DRUGS ANIM US | 3 | 29% | 0.7% | 10 |
2 | ANTI INFECT DISCOVERY GRP | 2 | 67% | 0.1% | 2 |
3 | EA 1156 | 2 | 67% | 0.1% | 2 |
4 | INNOVAT DRUGS | 2 | 67% | 0.1% | 2 |
5 | REIMBURSEMENT HLTH OUTCOMES | 2 | 67% | 0.1% | 2 |
6 | ANTI INFECT GRP | 1 | 100% | 0.1% | 2 |
7 | ANTIINFECT DISCOVERY GRP | 1 | 100% | 0.1% | 2 |
8 | ANTIMICROBIAL AGENTS TEAM | 1 | 50% | 0.1% | 2 |
9 | ASTRAZENECA DISCOVERY | 1 | 100% | 0.1% | 2 |
10 | GLOBAL PRICING | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000197781 | DAPTOMYCIN//TELAVANCIN//HVISA |
2 | 0.0000143800 | DALFOPRISTIN//QUINUPRISTIN//QUINUPRISTIN DALFOPRISTIN |
3 | 0.0000093769 | CEFTAROLINE//CEFTOBIPROLE//CEFTOLOZANE TAZOBACTAM |
4 | 0.0000085965 | TIGECYCLINE//GLYCYLCYCLINE//GLYCYLCYCLINES |
5 | 0.0000076378 | CYTOXAZONE//DYSIHERBAINE//HYDROXIMATE |
6 | 0.0000062652 | ENTEROCOCCUS//VANA//ENTEROCOCCI |
7 | 0.0000062325 | PLEUROMUTILIN//PLEUROMUTILIN DERIVATIVES//VALNEMULIN |
8 | 0.0000060325 | VANCOMYCIN//TEICOPLANIN//FUNCEI |
9 | 0.0000050592 | BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV |
10 | 0.0000050104 | EARLY BACTERICIDAL ACTIVITY//DELAMANID//BEDAQUILINE |